▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2307 by analyst upside · 2026-06-29
ELAN
Elanco Animal Health Incorporated
Healthcare · Market Cap $12B · P/E 0x
ANALYST PRICE TARGET
+21.5%
implied upside to consensus target
Current Price $24.57
Consensus Target $29.86
Bull Target $32.0
Bear Target $23.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
8
Hold
2
Sell
1
52-Week Low $13.39
52-Week High $27.72
YTD Return +9.1%
FUNDAMENTALS
Market Cap $12B
P/E Ratio (TTM) N/A
Forward P/E 20.7x
EPS (TTM) $-0.50
PEG Ratio 4.04
Dividend Yield N/A
Revenue (TTM) $4.9B
Profit Margin -4.9%
52-WEEK RANGE
52-Week Low $13.39
52-Week High $27.72
Current Price $24.57
Bear Target $23.0
Bull Target $32.0
● Now $24.57 ● Target $29.86
TRADING DATA
Avg Volume 5.8M
YTD Return +9.1%
Analyst Count 14
Consensus Buy
Upside to Target +21.5%
Last Updated 2026-06-29

ANALYST SUMMARY

Elanco Animal Health Incorporated (ELAN) is currently trading at $24.57 with a Wall Street consensus price target of $29.86, implying potential upside of 21.5% over the next 12 months. 14 analysts currently cover ELAN, with a consensus rating of Buy - 79% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $32.0, while the most cautious has a target of $23.0.

ELAN operates in the Healthcare sector with a market capitalisation of $12B. The stock is up 9.1% year-to-date and is currently trading near the upper end of its 52-week range of $13.39 – $27.72.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

GMED +26.0%
Globus Medical, Inc.
$12B · P/E 20.2x · Buy
FMS +9.4%
Fresenius Medical Care AG
$12B · P/E 12.5x · Hold
SNN +16.5%
Smith & Nephew plc
$13B · P/E 21.0x · Hold
SOLV +3.3%
Solventum Corporation
$14B · P/E 9.7x · Hold
ALGN +17.2%
Align Technology, Inc.
$13B · P/E 30.0x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ELAN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen — Reiterated
Buy → Buy 2026-06-18 Building track record
Citigroup — Reiterated
Buy → Buy 2026-05-07 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-05-07 43% win rate (7 calls)
Citigroup ● Initiated
Buy 2026-04-15 Building track record
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-02-25 Building track record
Keybanc — Reiterated
Overweight → Overweight 2026-02-25 Building track record
Leerink Partners — Reiterated
Outperform → Outperform 2026-02-24 29% win rate (7 calls)
JP Morgan — Reiterated
Overweight → Overweight 2026-02-19 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
58
out of 100
Coverage depth
21/30
Consensus clarity
23/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →